Cell-SELEX technology for aptamer selection

Gowtham Kenguva, Smruti Rekha Rout, Lopamudra Giri, Amirhossein Sahebkar, Prashant Kesharwani, Rambabu Dandela

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

2 Scopus citations

Abstract

Aptamers can be explained as mono-stranded structures which can be bound with any desired target molecules that can be found in huge combinatorial nucleic acid lists. Aptamers, like antibodies, attach to target molecules with specificity and high affinity. Aspects of aptamers, however, such as their resistance to lowering conditions and heat denaturation, provide additional benefits. It can be an appealing alternative to antibodies in medical applications and molecular biology because they possess a variety of desirable features. Aptamers are discovered using a method called systematic evolution of ligands by exponential enrichment, which involves an iterative selection–amplification process (SELEX). SELEX can be achieved on complete live cells as well as purified target molecules. Cell-SELEX is a unique method which possesses a number of benefits.

Original languageEnglish
Title of host publicationAptamers Engineered Nanocarriers for Cancer Therapy
PublisherElsevier
Pages1-20
Number of pages20
ISBN (Electronic)9780323858816
ISBN (Print)9780323900768
DOIs
StatePublished - 1 Jan 2022
Externally publishedYes

Keywords

  • Antibodies
  • Aptamers
  • DNA
  • RNA
  • SELEX
  • Target molecule

ASJC Scopus subject areas

  • General Medicine
  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Cell-SELEX technology for aptamer selection'. Together they form a unique fingerprint.

Cite this